Development and Validation of a Prognostic Model of Swallowing Recovery and Enteral Tube Feeding After Ischemic Stroke.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
01 05 2019
Historique:
pubmed: 12 2 2019
medline: 18 2 2020
entrez: 12 2 2019
Statut: ppublish

Résumé

Predicting the duration of poststroke dysphagia is important to guide therapeutic decisions. Guidelines recommend nasogastric tube (NGT) feeding if swallowing impairment persists for 7 days or longer and percutaneous endoscopic gastrostomy (PEG) placement if dysphagia does not recover within 30 days, but, to our knowledge, a systematic prediction method does not exist. To develop and validate a prognostic model predicting swallowing recovery and the need for enteral tube feeding. We enrolled participants with consecutive admissions for acute ischemic stroke and initially severe dysphagia in a prospective single-center derivation (2011-2014) and a multicenter validation (July 2015-March 2018) cohort study in 5 tertiary stroke referral centers in Switzerland. Severely impaired oral intake at admission (Functional Oral Intake Scale score <5). Recovery of oral intake (primary end point, Functional Oral Intake Scale ≥5) or return to prestroke diet (secondary end point) measured 7 (indication for NGT feeding) and 30 (indication for PEG feeding) days after stroke. In total, 279 participants (131 women [47.0%]; median age, 77 years [interquartile range, 67-84 years]) were enrolled (153 [54.8%] in the derivation study; 126 [45.2%] in the validation cohort). Overall, 64% (95% CI, 59-71) participants failed to recover functional oral intake within 7 days and 30% (95% CI, 24-37) within 30 days. Prolonged swallowing recovery was independently associated with poor outcomes after stroke. The final prognostic model, the Predictive Swallowing Score, included 5 variables: age, stroke severity on admission, lesion location, initial risk of aspiration, and initial impairment of oral intake. Predictive Swallowing Score prediction estimates ranged from 5% (score, 0) to 96% (score, 10) for a persistent impairment of oral intake on day 7 and from 2% to 62% on day 30. Model performance in the validation cohort showed a discrimination (C statistic) of 0.84 (95% CI, 0.76-0.91; P < .001) for predicting the recovery of oral intake on day 7 and 0.77 (95% CI, 0.67-0.87; P < .001) on day 30, and a discrimination for a return to prestroke diet of 0.94 (day 7; 95% CI, 0.87-1.00; P < .001) and 0.71 (day 30; 95% CI, 0.61-0.82; P < .001). Calibration plots showed high agreement between the predicted and observed outcomes. The Predictive Swallowing Score, available as a smartphone application, is an easily applied prognostic instrument that reliably predicts swallowing recovery. It will support decision making for NGT or PEG insertion after ischemic stroke and is a step toward personalized medicine.

Identifiants

pubmed: 30742198
pii: 2723504
doi: 10.1001/jamaneurol.2018.4858
pmc: PMC6515605
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-570

Références

J Stroke Cerebrovasc Dis. 2012 Feb;21(2):114-20
pubmed: 20851628
Gastroenterology. 1995 Apr;108(4):1282-301
pubmed: 7698596
Hum Brain Mapp. 2017 Apr;38(4):2165-2176
pubmed: 28083906
J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):236-41
pubmed: 2564884
Lancet. 2000 May 13;355(9216):1670-4
pubmed: 10905241
Stroke. 2013 Oct;44(10):2760-7
pubmed: 23887840
Clin Nutr. 2001 Oct;20(5):423-8
pubmed: 11534937
Neurology. 2014 Sep 2;83(10):874-82
pubmed: 25098538
Stroke. 2005 Dec;36(12):2756-63
pubmed: 16269630
Health Technol Assess. 2006 Jan;10(2):iii-iv, ix-x, 1-120
pubmed: 16409880
J Hum Nutr Diet. 2009 Apr;22(2):148-55
pubmed: 19302120
Arch Phys Med Rehabil. 2005 Aug;86(8):1516-20
pubmed: 16084801
J Stroke Cerebrovasc Dis. 2003 Jul-Aug;12(4):169-74
pubmed: 17903923
Stroke. 2015 Jun;46(6):1494-500
pubmed: 25953366
Stroke. 1999 Apr;30(4):744-8
pubmed: 10187872
Lancet. 2005 Feb 26-Mar 4;365(9461):764-72
pubmed: 15733717
Arch Neurol. 1992 Dec;49(12):1259-61
pubmed: 1449405
Dysphagia. 2017 Apr;32(2):209-215
pubmed: 28353151
Gut. 2003 Dec;52 Suppl 7:vii1-vii12
pubmed: 14612488
Asia Pac J Clin Nutr. 2015;24(3):379-86
pubmed: 26420177
Stroke. 2013 Nov;44(11):3232-4
pubmed: 23963332
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
J Stroke Cerebrovasc Dis. 2017 Mar;26(3):480-487
pubmed: 28041902
Exp Transl Stroke Med. 2013 Dec 01;5(1):14
pubmed: 24289189
NeuroRehabilitation. 2013;33(2):201-8
pubmed: 23949048
Lancet Neurol. 2007 Dec;6(12):1106-14
pubmed: 18031707
J Stroke Cerebrovasc Dis. 2014 Jan;23(1):56-62
pubmed: 23102742
J Hum Nutr Diet. 2005 Jun;18(3):213-9
pubmed: 15882384
Dysphagia. 1997 Fall;12(4):188-93
pubmed: 9294937
J Stroke Cerebrovasc Dis. 2012 Oct;21(7):569-76
pubmed: 21683618
Stroke. 1996 Jun;27(6):1028-32
pubmed: 8650709
Eur J Neurol. 2016 May;23(5):926-34
pubmed: 26901451
Nat Neurosci. 2010 Dec;13(12):1496-504
pubmed: 21057507

Auteurs

Marian Galovic (M)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.
National Institute for Health Research University College London (UCL) Hospitals Biomedical Research Centre, Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, England.
Magnetic Resonance Imaging Unit, Chalfont Centre for Epilepsy, Chalfont St Peter, England.

Anne Julia Stauber (AJ)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.

Natascha Leisi (N)

Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St Gallen, Switzerland.

Werner Krammer (W)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.

Florian Brugger (F)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.

Jochen Vehoff (J)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.

Philipp Balcerak (P)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.

Anna Müller (A)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.

Marlise Müller (M)

Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St Gallen, Switzerland.

Jochen Rosenfeld (J)

Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St Gallen, Switzerland.

Alexandros Polymeris (A)

Neurology and Stroke Centre, University Hospital Basel and University of Basel, Basel, Switzerland.

Sebastian Thilemann (S)

Neurology and Stroke Centre, University Hospital Basel and University of Basel, Basel, Switzerland.

Gian Marco De Marchis (GM)

Neurology and Stroke Centre, University Hospital Basel and University of Basel, Basel, Switzerland.

Thorsten Niemann (T)

Neurology and Stroke Centre, University Hospital Basel and University of Basel, Basel, Switzerland.

Maren Leifke (M)

Neurology and Stroke Centre, University Hospital Basel and University of Basel, Basel, Switzerland.

Philippe Lyrer (P)

Neurology and Stroke Centre, University Hospital Basel and University of Basel, Basel, Switzerland.

Petra Saladin (P)

Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland.

Timo Kahles (T)

Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland.

Krassen Nedeltchev (K)

Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland.
Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.

Hakan Sarikaya (H)

Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.

Simon Jung (S)

Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.

Urs Fischer (U)

Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.

Concetta Manno (C)

Stroke Center, Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Civico, Lugano, Switzerland.

Carlo W Cereda (CW)

Stroke Center, Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Civico, Lugano, Switzerland.

Josemir W Sander (JW)

National Institute for Health Research University College London (UCL) Hospitals Biomedical Research Centre, Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, England.
Magnetic Resonance Imaging Unit, Chalfont Centre for Epilepsy, Chalfont St Peter, England.
Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands.

Barbara Tettenborn (B)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.

Bruno J Weder (BJ)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.
Support Centre for Advanced Neuroimaging, Institute of Diagnostic and Interventional Neuroradiology, University Hospital Inselspital, University of Bern, Bern, Switzerland.

Sandro J Stoeckli (SJ)

Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St Gallen, Switzerland.

Marcel Arnold (M)

Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.

Georg Kägi (G)

Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH